This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Cytune Pharma, National Institute of Health and Medical Research. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2023
Title: Bruno Gilbert Marc Robert: Innovator in Immunocytokines
Introduction
Bruno Gilbert Marc Robert is a notable inventor based in Valflaunes, France. He has made significant contributions to the field of immunocytokines, holding a total of 3 patents. His work focuses on innovative solutions that enhance the efficacy of immunotherapy.
Latest Patents
His latest patents include the development of IL-15 and IL-15Rα sushi domain-based immunocytokines. These inventions relate to an immunocytokine that comprises a conjugate and an antibody or a fragment thereof, which is directly or indirectly linked by covalence to the conjugate. The conjugate includes a polypeptide with the amino acid sequence of interleukin 15 or its derivatives, along with a polypeptide that contains the amino acid sequence of the sushi domain of interleukin 15R alpha or its derivatives. These patents highlight the potential uses of these immunocytokines in therapeutic applications.
Career Highlights
Bruno has worked with prominent organizations such as Cytune Pharma and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Guy Luc Michel De Martynoff and Sebastien Daniel Morisseau. Their collaborative efforts have further enriched the research environment in which Bruno operates.
Conclusion
Bruno Gilbert Marc Robert is a distinguished inventor whose work in immunocytokines is paving the way for advancements in immunotherapy. His patents and collaborations reflect his commitment to innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile